Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 23.1B | 21.0B | 20.4B | 20.3B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.0B | 997M | 886.6M | 712.6M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 17.8B | 18.0B | 16.7B | 16.4B |
Tax provision | 4.1B | 3.6B | 3.4B | 3.3B |
Net income | 13.7B | 14.3B | 13.3B | 13.1B |
Basic EPS | — | 26.1 | 24.1 | 23.8 |
Diluted EPS | — | 26.1 | 24.1 | 23.8 |
Basic average shares | — | 550.0M | 550.1M | 550.0M |
Diluted average shares | — | 550.0M | 550.1M | 550.0M |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -2.4M | -500K | -800K | -1M |
Preferred stock dividends | — | — | — | — |